lymphocyte count follicular phase
Selected indexed studies
- Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. (Science, 2008) [PMID:18703743]
- Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial. (Int J Hematol, 2021) [PMID:33864623]
- The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial. (Clin Cancer Res, 2023) [PMID:36735519]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The immune response during the luteal phase of the ovarian cycle: a Th2-type response? (2000) pubmed
- The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin. (2001) pubmed
- The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial. (2023) pubmed
- Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. (2008) pubmed
- Safety and efficacy of amulirafusp alfa (IMM0306), a fusion protein of CD20 monoclonal antibody with the CD47 binding domain of SIRPα, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a phase 1/2 study. (2024) pubmed
- Immunopathogenic mechanisms of HIV infection. (1996) pubmed
- Ocular manifestations of coronavirus disease 2019. (2020) pubmed
- Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial. (2021) pubmed
- γδ T cells modulate humoral immunity against Plasmodium berghei infection. (2018) pubmed
- Leukemic phase of follicular lymphoma after treatment with etanercept in a patient with psoriasis. (2009) pubmed